Karen Sundell

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

Lawrence S. Honig, Bruno Vellas, Merçé Boada et al. · New England Journal of Medicine · 2018 · 1K citations · Full text

Medicine, Neurology, Pharmacology +17

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients

Eric Siemers, Karen Sundell, Christopher Carlson et al. · Alzheimer s & Dementia · 2015 · 365 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Optimal Length of Continuation Therapy in Depression: A Prospective Assessment During Long-Term Fluoxetine Treatment

Frederick W. Reimherr, Jay D. Amsterdam, Frederic M. Quitkin et al. · American Journal of Psychiatry · 1998 · 203 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Changes in Weight During a 1-Year Trial of Fluoxetine

David Michelson, Jay D. Amsterdam, Fred Reimherr et al. · American Journal of Psychiatry · 1999 · 169 citations

Medicine, Pharmacology, Pharmacotherapy +17

Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor

Lawrence J. Slieker, Gerald S. Brooke, Richard D. DiMarchi et al. · Diabetologia · 1997 · 140 citations · Full text

Life Sciences, Biochemistry, Endocrinology +8